KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · Real-Time Price · USD

26.66

+0.01 (0.04%)

At close: May 4, 2026, 4:00 PM EDT

26.74

+0.08 (0.30%)

Pre-market: May 5, 2026, 5:06 AM EDT

KalVista Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2017	FY 2016	FY 2015
Period Ending	May '26 May 4, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '17 Apr 30, 2017	Apr '16 Apr 30, 2016	Dec '15 Dec 31, 2015
Market Cap	1,366	685	483	73	22	261,469
Market Cap Growth	128.90%	41.98%	563.39%	227.48%	-99.99%	-27.88%
Enterprise Value	1,350	574.82	278.24	72.75	22.22	261,469
Last Close Price	26.66	13.77	11.35	7.49	10.25	50.68
PE Ratio	-	-3.73	-3.30	-	-	-
PB Ratio	-	7.18	2.34	-	-	-
P/TBV Ratio	79.27	7.17	2.02	-	-	-
P/FCF Ratio	-	-4.47	-5.41	-	-	-
P/OCF Ratio	-	-4.48	-5.41	-	-	-
EV/EBITDA Ratio	-	-3.07	-1.99	-	-	-
EV/EBIT Ratio	-	-3.06	-1.98	-	-	-
EV/FCF Ratio	-	-3.75	-3.12	-	-	-
Debt / Equity Ratio	16.35	1.16	0.03	-	-	-
Debt / EBITDA Ratio	-	-0.60	-0.05	-	-	-
Debt / FCF Ratio	-	-0.73	-0.08	-	-	-
Net Debt / Equity Ratio	-1.56	-1.14	-0.98	-	-	-
Net Debt / EBITDA Ratio	-	0.58	1.45	-	-	-
Net Debt / FCF Ratio	-	0.71	2.28	-	-	-
Quick Ratio	7.02	4.92	9.60	-	-	-
Current Ratio	7.22	5.35	9.90	-	-	-
Return on Equity (ROE)	-	-121.50%	-61.30%	-	-	-
Return on Assets (ROA)	-	-78.79%	-59.66%	-	-	-
Return on Invested Capital (ROIC)	-	-26219.90%	-4015.01%	-	-	-
Return on Capital Employed (ROCE)	-	-89.91%	-66.06%	-	-	-
Earnings Yield	-12.03%	-26.80%	-30.31%	0.00%	0.00%	0.00%
FCF Yield	-9.15%	-22.38%	-18.50%	0.00%	0.00%	0.00%
Buyback Yield / Dilution	-12.32%	-34.98%	-	-	-	-
Total Shareholder Return	-12.32%	-34.98%	-	-	-	-

Updated Nov 11, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q